Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two decades of experimental and clinical orthotopic homotransplantation of the heart.

Perspectives in biology and medicine·2015
Same author

Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study.

Circulation·2001
Same author

Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis.

The Annals of thoracic surgery·2001
Same author

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

Circulation·1999
Same author

Thirty years of cardiac transplantation at Stanford university.

The Journal of thoracic and cardiovascular surgery·1999
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

Cardiac transplantation

S A Hunt, E B Stinson

    Annual Review of Medicine
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Orthotopic cardiac transplantation is a viable treatment for end-stage heart disease, offering high survival and rehabilitation rates. Advances in immunosuppression are key to improving long-term outcomes for heart transplant patients.

    More Related Videos

    A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
    08:30

    A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

    Published on: February 14, 2022

    Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
    08:44

    Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

    Published on: June 23, 2022

    Related Experiment Videos

    Last Updated: Jun 23, 2026

    Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
    10:32

    Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

    Published on: October 12, 2014

    A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
    08:30

    A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

    Published on: February 14, 2022

    Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
    08:44

    Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

    Published on: June 23, 2022

    Area of Science:

    • Cardiology
    • Transplantation Medicine
    • Immunology

    Background:

    • End-stage heart disease (EHD) significantly impacts patient prognosis.
    • Inoperable EHD necessitates advanced therapeutic interventions.
    • Cardiac transplantation is a potential solution for select EHD patients.

    Purpose of the Study:

    • To evaluate orthotopic cardiac transplantation as a treatment for inoperable end-stage heart disease.
    • To assess survival and rehabilitation outcomes following cardiac transplantation.
    • To identify factors influencing survival rates in heart transplant recipients.

    Main Methods:

    • Retrospective analysis of 188 patients undergoing orthotopic cardiac transplantation at Stanford.
    • Comparison of survival rates with cadaver renal transplant series.
    • Assessment of patient rehabilitation potential.

    Main Results:

    • Orthotopic cardiac transplantation is a reasonable therapeutic option for patients with inoperable end-stage heart disease.
    • Survival expectations are comparable to cadaver renal transplantation.
    • Rehabilitation potential exceeds 90% for eligible patients.

    Conclusions:

    • Cardiac transplantation offers significant benefits for patients with inoperable end-stage heart disease.
    • Current survival limitations are primarily linked to immunosuppression strategies.
    • Future advancements in immunosuppression are expected to enhance cardiac transplant outcomes.